Clinical AI
Liquid Biopsy Wins Every Discordant Case Against Tumor-Informed Tests in Head-to-Head Cancer Monitoring Study
BillionToOne's tissue-free blood test matched imaging and biopsy in 100% of mismatches with traditional ctDNA assays, challenging the tumor-informed paradigm in a 169-sample validation study.
Health AI Central Editorial Team·October 8, 2026